Analyst Ratings for Portola Pharmaceuticals (PTLA)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 1.4 / 10
Percentile Rank: 10%
Rating Score: 1.4 / 10
Percentile Rank: 10%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/5/2020 | Citi | Yigal Nochomovitz | Downgrade | Neutral (Buy) |
18.00 (31.00) |
7.76 (18.03) |
132.35% | Details |
| 5/5/2020 | William Blair | Matt Phipps | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
7.76 (18.03) |
132.35% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
